Radiotherapy & Oncology
Volume 93, Issue 2 , Pages 203-206 , November 2009

Late toxicity after postprostatectomy salvage radiation therapy

  • Jennifer L. Peterson

      Affiliations

    • Department of Radiation Oncology, Jacksonville, FL, USA
    • ,
  • Steven J. Buskirk

      Affiliations

    • Department of Radiation Oncology, Jacksonville, FL, USA
    • Corresponding Author InformationCorresponding author. Address: Department of Radiation Oncology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, USA.
    • ,
  • Michael G. Heckman

      Affiliations

    • Biostatistics Unit, Jacksonville, FL, USA
    • ,
  • Julia E. Crook

      Affiliations

    • Biostatistics Unit, Jacksonville, FL, USA
    • ,
  • Stephen J. Ko

      Affiliations

    • Department of Radiation Oncology, Jacksonville, FL, USA
    • ,
  • Michael J. Wehle

      Affiliations

    • Department of Urology, Jacksonville, FL, USA
    • ,
  • Todd C. Igel

      Affiliations

    • Department of Urology, Jacksonville, FL, USA
    • ,
  • Karin A. Prussak

      Affiliations

    • Department of Radiation Oncology, Jacksonville, FL, USA
    • ,
  • Thomas M. Pisansky

      Affiliations

    • Department of Radiation Oncology, Rochester, MN, USA

Received 8 December 2008 ,Revised 21 August 2009 ,Accepted 24 August 2009.

References 

  1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics. CA Cancer J Clin. 2009;59:225–249
  2. Stephenson RA. Prostate cancer trends in the era of prostate-specific antigen: an update of incidence, mortality, and clinical factors from the SEER database. Urol Clin North Am. 2002;29:173–181
  3. Cooperberg MR, Broering JM, Litwin MS, Lubeck DP, Mehta SS, Henning JM, et al. CaPSURE Investigators. The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CaPSURE), a national disease registry. J Urol 2004;171:1393–401.
  4. Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC. Natural history of progression after PSA elevation following radical prostatectomy. JAMA. 1999;281:1591–1597
  5. Pisansky TM, Kozelsky TF, Myers RP, Hillman DW, Blute ML, Buskirk SJ, et al. Radiotherapy for isolated serum prostate-specific antigen elevation after prostatectomy for prostate cancer. J Urol. 2000;163:845–850
  6. Stephenson AJ, Scardino PT, Kattan MW, Pisansky TM, Slawin KM, Klein EA, et al. Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J Clin Oncol. 2007;25:2035–2041Erratum in: J Clin Oncol 2007;25:4153
  7. Buskirk SJ, Pisansky TM, Schild SE, Macdonald OK, Wehle MJ, Kozelsky TF, et al. Salvage radiotherapy for isolated prostate-specific antigen increase after radical prostatectomy: evaluation of prognostic factors and creation of a prognostic scoring system. J Urol. 2006;176:985–990
  8. O’Leary MP, Baum NH, Blizzard R, Blute ML, Cooper TP, Dineen MK, et al. The Health Policy Survey and Research Committee. 2001 American Urological Association Gallup Survey: changes in physician practice patterns, satisfaction with urology, and treatment of prostate cancer and erectile dysfunction. J Urol 2002;168:649–52.
  9. Taylor N, Kelly JF, Kuban DA, Babaian RJ, Pisters LL, Pollack A. Adjuvant and salvage radiotherapy after radical prostatectomy for prostate cancer. Int J Radiat Oncol Biol Phys. 2003;56:755–763
  10. Zelefsky MJ, Aschkenasy E, Kelsen S, Leibel SA. Tolerance and early outcome results of postprostatectomy three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys. 1997;39:327–333
  11. Bolla M, van Poppel H, Collette L, Van Cangh P, Vekemans K, Da Pozzo L, et al. European Organization for Research and Treatment of Cancer. Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911). Lancet. 2005;366:572–8.
  12. Formenti SC, Lieskovsky G, Simoneau AR, Skinner D, Groshen S, Chen SC, et al. Impact of moderate dose of postoperative radiation on urinary continence and potency in patients with prostate cancer treated with nerve sparing prostatectomy. J Urol. 1996;155:616–619
  13. Jacobson GM, Smith JA, Stewart JR. Postoperative radiation therapy for pathologic stage C prostate cancer. Int J Radiat Oncol Biol Phys. 1987;13:1021–1024
  14. Macdonald OK, Schild SE, Vora SA, Andrews PE, Ferrigni RG, Novicki DE, et al. Radiotherapy for men with isolated increase in serum prostate-specific antigen after radical prostatectomy. J Urol. 2003;170:1833–1837
  15. Pilepich MV, Walz BJ, Baglan RJ. Postoperative irradiation in carcinoma of the prostate. Int J Radiat Oncol Biol Phys. 1984;10:1869–1873
  16. Choo R, Hruby G, Hong J, Bahk E, Hong E, Danjoux C, et al. (IN)-efficacy of salvage radiotherapy for rising PSA or clinically isolated local recurrence after radical prostatectomy. Int J Radiat Oncol Biol Phys. 2002;53:269–276
  17. Forman JD, Duclos M, Shamsa F, Pontes EJ. Predicting the need for adjuvant systemic therapy in patients receiving postprostatectomy irradiation. Urology. 1996;47:382–386
  18. Wu JJ, King SC, Montana GS, McKinstry CA, Anscher MS. The efficacy of postprostatectomy radiotherapy in patients with an isolated elevation of serum prostate-specific antigen. Int J Radiat Oncol Biol Phys. 1995;32:317–323
  19. Morris MM, Dallow KC, Zietman AL, Park J, Althausen A, Heney NM, et al. Adjuvant and salvage irradiation following radical prostatectomy for prostate cancer. Int J Radiat Oncol Biol Phys. 1997;38:731–736
  20. Van Cangh PJ, Richard F, Lorge F, Castille Y, Moxhon A, Opsomer R, et al. Adjuvant radiation therapy does not cause urinary incontinence after radical prostatectomy: results of a prospective randomized study. J Urol. 1998;159:164–166
  21. Lennernas B, Edgren M, Haggman M, Norlen BJ, Nilsson S. Postoperative radiotherapy after prostatectomy: a review. Scand J Urol Nephrol. 2003;37:10–15
  22. Bolla M, van Poppel H, Van Cangh PJ, Scalliet P, van den Bogaert W, Vekemans K, et al. Acute and late toxicity of post-operative external irradiation in pT3N0 prostate cancer patients treated within EORTC trial 22911 [abstract]. Int J Radiat Oncol Biol Phys. 2002;54:62–63
  23. Thompson IM, Tangen CM, Paradelo J, Lucia MS, Miller G, Troyer D, et al. Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial. JAMA. 2006;296:2329–2335
  24. Feng M, Hanlon AL, Pisansky TM, Kuban D, Catton CN, Michalski JM, et al. Predictive factors for late genitourinary and gastrointestinal toxicity in patients with prostate cancer treated with adjuvant or salvage radiotherapy. Int J Radiat Oncol Biol Phys. 2007;68:1417–1423
  25. Lerner SE, Blute ML, Lieber MM, Zincke H. Morbidity of contemporary radical retropubic prostatectomy for localized prostate cancer. Oncology (Williston Park). 1995;9:379–382
  26. Geary ES, Dendinger TE, Freiha FS, Stamey TA. Incontinence and vesical neck strictures following radical retropubic prostatectomy. Urology. 1995;45:1000–1006
  27. Kao TC, Cruess DF, Garner D, Foley J, Seay T, Friedrichs P, et al. Multicenter patient self-reporting questionnaire on impotence, incontinence and stricture after radical prostatectomy. J Urol. 2000;163:858–864
  28. Diokno AC, Brock BM, Brown MB, Herzog AR. Prevalence of urinary incontinence and other urological symptoms in the noninstitutionalized elderly. J Urol. 1986;136:1022–1025
  29. Cozzarini C, Bolognesi A, Ceresoli GL, Fiorino C, Rossa A, Bertini R, et al. Role of postoperative radiotherapy after pelvic lymphadenectomy and radical retropubic prostatectomy: a single institute experience of 415 patients. Int J Radiat Oncol Biol Phys. 2004;59:674–683
  30. Poortmans P, Bossi A, Vandeputte K, Bosset M, Miralbell R, Maingon P, et al. EORTC Radiation Oncology Group. Guidelines for target volume definition in post-operative radiotherapy for prostate cancer, on behalf of the EORTC Radiation Oncology Group. Radiother Oncol 2007;84:121–7.

PII: S0167-8140(09)00468-X

doi: 10.1016/j.radonc.2009.08.035

Radiotherapy & Oncology
Volume 93, Issue 2 , Pages 203-206 , November 2009

Article Tools

* Image Usage & Resolution